Status: Recruiting
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
Phase II clinical study of HRS-9057 injection in patients with heart failure-induced fluid retention
Participants needed: 153
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Jun 1, 2026Locations: 1
Eligibility criteria
Aged ≥18 years on the day of signing the informed consent, regardless of gender; [+4]
Occurrence of myocardial infarction, stroke or transient ischemic attack, sustai... [+14]